HEADER HYDROLASE (CARBOXYLIC ESTERASE) 11-JUL-95 1LBT TITLE LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROL HYDROLASE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIPASE B; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TRIACYLGLYCEROL HYDROLASE; COMPND 5 EC: 3.1.1.3 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA ANTARCTICA; SOURCE 3 ORGANISM_TAXID: 34362 KEYWDS HYDROLASE (CARBOXYLIC ESTERASE) EXPDTA X-RAY DIFFRACTION AUTHOR J.UPPENBERG,T.A.JONES REVDAT 8 30-OCT-24 1LBT 1 HETSYN REVDAT 7 29-JUL-20 1LBT 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE ATOM REVDAT 6 29-NOV-17 1LBT 1 HELIX REVDAT 5 13-JUL-11 1LBT 1 VERSN REVDAT 4 24-FEB-09 1LBT 1 VERSN REVDAT 3 01-APR-03 1LBT 1 JRNL REVDAT 2 06-OCT-99 1LBT 1 JRNL REVDAT 1 15-OCT-95 1LBT 0 JRNL AUTH J.UPPENBERG,N.OHRNER,M.NORIN,K.HULT,G.J.KLEYWEGT,S.PATKAR, JRNL AUTH 2 V.WAAGEN,T.ANTHONSEN,T.A.JONES JRNL TITL CRYSTALLOGRAPHIC AND MOLECULAR-MODELING STUDIES OF LIPASE B JRNL TITL 2 FROM CANDIDA ANTARCTICA REVEAL A STEREOSPECIFICITY POCKET JRNL TITL 3 FOR SECONDARY ALCOHOLS. JRNL REF BIOCHEMISTRY V. 34 16838 1995 JRNL REFN ISSN 0006-2960 JRNL PMID 8527460 JRNL DOI 10.1021/BI00051A035 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.UPPENBERG,S.PATKAR,T.BERGFORS,T.A.JONES REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY STUDIES OF LIPASE B REMARK 1 TITL 2 FROM CANDIDA ANTARCTICA REMARK 1 REF J.MOL.BIOL. V. 235 790 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.UPPENBERG,M.T.HANSEN,S.PATKAR,T.A.JONES REMARK 1 TITL THE SEQUENCE, CRYSTAL STRUCTURE DETERMINATION AND REFINEMENT REMARK 1 TITL 2 OF TWO CRYSTAL FORMS OF LIPASE B FROM CANDIDA ANTARCTICA REMARK 1 REF STRUCTURE V. 2 293 1994 REMARK 1 REFN ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 25854 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4648 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 128 REMARK 3 SOLVENT ATOMS : 155 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.300 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LBT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174647. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-90 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : XUONG-HAMLIN MULTIWIRE MARK III REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MARK III, SDMS REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26677 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.0 REMARK 200 DATA REDUNDANCY : 1.700 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.10000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MTRIX REMARK 300 THE TRANSFORMATIONS PRESENTED ON MTRIX RECORDS BELOW REMARK 300 DESCRIBE NON-CRYSTALLOGRAPHIC RELATIONSHIPS AMONG THE REMARK 300 VARIOUS DOMAINS IN THIS ENTRY. APPLYING THE APPROPRIATE REMARK 300 MTRIX TRANSFORMATION TO THE RESIDUES LISTED FIRST WILL REMARK 300 YIELD APPROXIMATE COORDINATES FOR THE RESIDUES LISTED REMARK 300 SECOND. REMARK 300 REMARK 300 APPLIED TO TRANSFORMED TO REMARK 300 MTRIX RESIDUES RESIDUES RMSD REMARK 300 M1 A 1 .. A 317 ? 1 .. ? 317 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 29 46.45 -157.49 REMARK 500 ASN A 51 -88.96 -144.02 REMARK 500 ASP A 75 122.13 -37.33 REMARK 500 SER A 105 -119.03 52.04 REMARK 500 ASP A 134 69.55 -113.46 REMARK 500 THR A 186 43.59 -91.53 REMARK 500 GLN A 193 12.90 -141.23 REMARK 500 ASN A 206 -0.34 75.69 REMARK 500 ASP A 223 -159.57 -80.12 REMARK 500 SER B 29 46.43 -157.51 REMARK 500 ASN B 51 -88.97 -144.00 REMARK 500 ASP B 75 122.10 -37.33 REMARK 500 SER B 105 -119.01 52.02 REMARK 500 ASP B 134 69.52 -113.45 REMARK 500 THR B 186 43.61 -91.49 REMARK 500 GLN B 193 12.88 -141.25 REMARK 500 ASN B 206 -0.30 75.76 REMARK 500 ASP B 223 -159.59 -80.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: CT2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL DBREF 1LBT A 1 317 UNP P41365 LIPB_CANAR 26 342 DBREF 1LBT B 1 317 UNP P41365 LIPB_CANAR 26 342 SEQRES 1 A 317 LEU PRO SER GLY SER ASP PRO ALA PHE SER GLN PRO LYS SEQRES 2 A 317 SER VAL LEU ASP ALA GLY LEU THR CYS GLN GLY ALA SER SEQRES 3 A 317 PRO SER SER VAL SER LYS PRO ILE LEU LEU VAL PRO GLY SEQRES 4 A 317 THR GLY THR THR GLY PRO GLN SER PHE ASP SER ASN TRP SEQRES 5 A 317 ILE PRO LEU SER THR GLN LEU GLY TYR THR PRO CYS TRP SEQRES 6 A 317 ILE SER PRO PRO PRO PHE MET LEU ASN ASP THR GLN VAL SEQRES 7 A 317 ASN THR GLU TYR MET VAL ASN ALA ILE THR ALA LEU TYR SEQRES 8 A 317 ALA GLY SER GLY ASN ASN LYS LEU PRO VAL LEU THR TRP SEQRES 9 A 317 SER GLN GLY GLY LEU VAL ALA GLN TRP GLY LEU THR PHE SEQRES 10 A 317 PHE PRO SER ILE ARG SER LYS VAL ASP ARG LEU MET ALA SEQRES 11 A 317 PHE ALA PRO ASP TYR LYS GLY THR VAL LEU ALA GLY PRO SEQRES 12 A 317 LEU ASP ALA LEU ALA VAL SER ALA PRO SER VAL TRP GLN SEQRES 13 A 317 GLN THR THR GLY SER ALA LEU THR THR ALA LEU ARG ASN SEQRES 14 A 317 ALA GLY GLY LEU THR GLN ILE VAL PRO THR THR ASN LEU SEQRES 15 A 317 TYR SER ALA THR ASP GLU ILE VAL GLN PRO GLN VAL SER SEQRES 16 A 317 ASN SER PRO LEU ASP SER SER TYR LEU PHE ASN GLY LYS SEQRES 17 A 317 ASN VAL GLN ALA GLN ALA VAL CYS GLY PRO LEU PHE VAL SEQRES 18 A 317 ILE ASP HIS ALA GLY SER LEU THR SER GLN PHE SER TYR SEQRES 19 A 317 VAL VAL GLY ARG SER ALA LEU ARG SER THR THR GLY GLN SEQRES 20 A 317 ALA ARG SER ALA ASP TYR GLY ILE THR ASP CYS ASN PRO SEQRES 21 A 317 LEU PRO ALA ASN ASP LEU THR PRO GLU GLN LYS VAL ALA SEQRES 22 A 317 ALA ALA ALA LEU LEU ALA PRO ALA ALA ALA ALA ILE VAL SEQRES 23 A 317 ALA GLY PRO LYS GLN ASN CYS GLU PRO ASP LEU MET PRO SEQRES 24 A 317 TYR ALA ARG PRO PHE ALA VAL GLY LYS ARG THR CYS SER SEQRES 25 A 317 GLY ILE VAL THR PRO SEQRES 1 B 317 LEU PRO SER GLY SER ASP PRO ALA PHE SER GLN PRO LYS SEQRES 2 B 317 SER VAL LEU ASP ALA GLY LEU THR CYS GLN GLY ALA SER SEQRES 3 B 317 PRO SER SER VAL SER LYS PRO ILE LEU LEU VAL PRO GLY SEQRES 4 B 317 THR GLY THR THR GLY PRO GLN SER PHE ASP SER ASN TRP SEQRES 5 B 317 ILE PRO LEU SER THR GLN LEU GLY TYR THR PRO CYS TRP SEQRES 6 B 317 ILE SER PRO PRO PRO PHE MET LEU ASN ASP THR GLN VAL SEQRES 7 B 317 ASN THR GLU TYR MET VAL ASN ALA ILE THR ALA LEU TYR SEQRES 8 B 317 ALA GLY SER GLY ASN ASN LYS LEU PRO VAL LEU THR TRP SEQRES 9 B 317 SER GLN GLY GLY LEU VAL ALA GLN TRP GLY LEU THR PHE SEQRES 10 B 317 PHE PRO SER ILE ARG SER LYS VAL ASP ARG LEU MET ALA SEQRES 11 B 317 PHE ALA PRO ASP TYR LYS GLY THR VAL LEU ALA GLY PRO SEQRES 12 B 317 LEU ASP ALA LEU ALA VAL SER ALA PRO SER VAL TRP GLN SEQRES 13 B 317 GLN THR THR GLY SER ALA LEU THR THR ALA LEU ARG ASN SEQRES 14 B 317 ALA GLY GLY LEU THR GLN ILE VAL PRO THR THR ASN LEU SEQRES 15 B 317 TYR SER ALA THR ASP GLU ILE VAL GLN PRO GLN VAL SER SEQRES 16 B 317 ASN SER PRO LEU ASP SER SER TYR LEU PHE ASN GLY LYS SEQRES 17 B 317 ASN VAL GLN ALA GLN ALA VAL CYS GLY PRO LEU PHE VAL SEQRES 18 B 317 ILE ASP HIS ALA GLY SER LEU THR SER GLN PHE SER TYR SEQRES 19 B 317 VAL VAL GLY ARG SER ALA LEU ARG SER THR THR GLY GLN SEQRES 20 B 317 ALA ARG SER ALA ASP TYR GLY ILE THR ASP CYS ASN PRO SEQRES 21 B 317 LEU PRO ALA ASN ASP LEU THR PRO GLU GLN LYS VAL ALA SEQRES 22 B 317 ALA ALA ALA LEU LEU ALA PRO ALA ALA ALA ALA ILE VAL SEQRES 23 B 317 ALA GLY PRO LYS GLN ASN CYS GLU PRO ASP LEU MET PRO SEQRES 24 B 317 TYR ALA ARG PRO PHE ALA VAL GLY LYS ARG THR CYS SER SEQRES 25 B 317 GLY ILE VAL THR PRO MODRES 1LBT ASN A 74 ASN GLYCOSYLATION SITE MODRES 1LBT ASN B 74 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET T80 A 900 36 HET T80 B 900 36 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM T80 METHYLPENTA(OXYETHYL) HEPTADECANOATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 5 T80 2(C29 H58 O7) FORMUL 7 HOH *155(H2 O) HELIX 1 A1 LYS A 13 ALA A 18 1 6 HELIX 2 A2 GLY A 44 THR A 57 1 14 HELIX 3 A3 THR A 76 GLY A 93 1 18 HELIX 4 A4 GLN A 106 PHE A 117 1 12 HELIX 5 A5 GLY A 142 ALA A 146 1 5 HELIX 6 A6 PRO A 152 GLN A 156 1 5 HELIX 7 A7 ALA A 162 ASN A 169 1 8 HELIX 8 A8 ALA A 212 CYS A 216 1 5 HELIX 9 A9 GLY A 226 ARG A 242 1 17 HELIX 10 A10 PRO A 268 ALA A 287 1 20 HELIX 11 TH1 PRO A 119 ILE A 121 5 3 HELIX 12 TH2 VAL A 139 ALA A 141 5 3 HELIX 13 TH3 SER A 250 ASP A 252 5 3 HELIX 14 TH4 ILE A 255 ASP A 257 5 3 HELIX 15 TH5 ARG A 302 PHE A 304 5 3 HELIX 16 P1 PRO A 68 PRO A 70 10 3 HELIX 17 B1 LYS B 13 ALA B 18 1 6 HELIX 18 B2 GLY B 44 THR B 57 1 14 HELIX 19 B3 THR B 76 GLY B 93 1 18 HELIX 20 B4 GLN B 106 PHE B 117 1 12 HELIX 21 B5 GLY B 142 ALA B 146 1 5 HELIX 22 B6 PRO B 152 GLN B 156 1 5 HELIX 23 B7 ALA B 162 ASN B 169 1 8 HELIX 24 B8 ALA B 212 CYS B 216 1 5 HELIX 25 B9 GLY B 226 ARG B 242 1 17 HELIX 26 B10 PRO B 268 ALA B 287 1 20 HELIX 27 BH1 PRO B 119 ILE B 121 5 3 HELIX 28 BH2 VAL B 139 ALA B 141 5 3 HELIX 29 BH3 SER B 250 ASP B 252 5 3 HELIX 30 BH4 ILE B 255 ASP B 257 5 3 HELIX 31 BH5 ARG B 302 PHE B 304 5 3 HELIX 32 P1B PRO B 68 PRO B 70 10 3 SHEET 1 S1 7 LEU A 20 CYS A 22 0 SHEET 2 S1 7 THR A 62 ILE A 66 -1 SHEET 3 S1 7 PRO A 33 VAL A 37 1 SHEET 4 S1 7 LEU A 99 TRP A 104 1 SHEET 5 S1 7 VAL A 125 PHE A 131 1 SHEET 6 S1 7 THR A 179 TYR A 183 1 SHEET 7 S1 7 LYS A 208 GLN A 211 1 SHEET 1 S2 2 ARG A 309 THR A 310 0 SHEET 2 S2 2 GLY A 313 ILE A 314 -1 SHEET 1 S3 7 LEU B 20 CYS B 22 0 SHEET 2 S3 7 THR B 62 ILE B 66 -1 SHEET 3 S3 7 PRO B 33 VAL B 37 1 SHEET 4 S3 7 LEU B 99 TRP B 104 1 SHEET 5 S3 7 VAL B 125 PHE B 131 1 SHEET 6 S3 7 THR B 179 TYR B 183 1 SHEET 7 S3 7 LYS B 208 GLN B 211 1 SHEET 1 S4 2 ARG B 309 THR B 310 0 SHEET 2 S4 2 GLY B 313 ILE B 314 -1 SSBOND 1 CYS A 22 CYS A 64 1555 1555 2.02 SSBOND 2 CYS A 216 CYS A 258 1555 1555 2.03 SSBOND 3 CYS A 293 CYS A 311 1555 1555 2.03 SSBOND 4 CYS B 22 CYS B 64 1555 1555 2.02 SSBOND 5 CYS B 216 CYS B 258 1555 1555 2.03 SSBOND 6 CYS B 293 CYS B 311 1555 1555 2.03 LINK ND2 ASN A 74 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN B 74 C1 NAG D 1 1555 1555 1.46 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 CISPEP 1 PRO A 69 PRO A 70 0 -0.15 CISPEP 2 GLN A 191 PRO A 192 0 0.00 CISPEP 3 PRO B 69 PRO B 70 0 -0.18 CISPEP 4 GLN B 191 PRO B 192 0 -0.01 SITE 1 CT 3 SER A 105 ASP A 187 HIS A 224 SITE 1 CT2 3 SER B 105 ASP B 187 HIS B 224 CRYST1 95.100 50.200 99.500 90.00 90.60 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010515 0.000000 0.000110 0.00000 SCALE2 0.000000 0.019920 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010051 0.00000 MTRIX1 1 -0.033200 0.007500 -0.999400 46.86330 1 MTRIX2 1 -0.005700 -1.000000 -0.007300 48.28900 1 MTRIX3 1 -0.999400 0.005500 0.033200 49.58020 1